ASHG 2026 · Tier 1 Academic

University of Edinburgh at ASHG 2026

Edinburgh, UK

University of Edinburgh at ASHG 2026 in Montréal: 5 presentations (4 posters, 1 lightning talk); 3 research groups.

5
presentations on the program
3
research groups identified
1
Reviewers’ Choice abstracts

Explore everyone at ASHG 2026 →

OrganizationASHG 2026 Attendance
University of Edinburgh
Edinburgh, UK
2 Postdocs · 2 PhD Students
Genetic Targets and Precision Medicineprecmed.cphs.mvm.ed.ac.uk
Dry lab~6 people
Uses deidentified electronic health records, genetic and biomarker data, and GENOSCORES. Prioritizes drug targets and informs diagnosis, prognosis, treatment and drug-safety decisions.
Funded by European Foundation for the Study of Diabetes, Diabetes UK +5 more
Diabetes UK, Real-world pharmacoepidemiology of drugs used in diabetes · 2/1/25 → 1/1/2028
“Real-world pharmacoepidemiology of drugs used in diabetes: harnessing e-health records and artificial intelligence. Colhoun H, McKeigue P. Diabetes UK 2/1/25 → 1/1/2028.”
European Foundation for the Study of Diabetes, Identifying drug targets for type 1 diabetes by genome-wide aggregated trans-effects analysis · 1/3/26 → 28/2/27
“Identifying drug targets for type 1 diabetes by genome-wide aggregated trans-effects analysis. European Foundation for the Study of Diabetes 1/3/26 → 28/2/27.”
Iqvia Ltd, EXCEED · 01/07/21 → 01/05/27
“EXCEED - A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients who Initiated Exenatide as Compared with those who Initiated Other non-Glucagon-Like Peptide 1 Receptor Agonists Colhoun H, McKeigue P. Iqvia Ltd 01/07/21 → 01/05/27.”
+4 more on the lab page
Source: lab pages
11 platforms and techniques
Analyzes
GENOSCORES, Deidentified electronic-health-record analysis platform, SomaScan, Olink
Techniques
Statistical genetics, Bayesian methods, Machine learning, Genome-wide aggregated trans-effects analysis, Trans-eQTL analysis, Trans-pQTL analysis, Causal inference
Source: lab pages
No openings posted
Talk
Wed Oct 21
2:03 pm
Genome-wide aggregated trans-effects analysis reveals B-cell activation and checkpoint signalling as therapeutic axes in primary biliary cholangitis
Decoding Genetic Risk Across Ancestry and Sex in Polygenic Disorders
Collaborators: Toronto General Hospital, Lunenfeld-Tanenbaum Research Institute
Genome-wide association studyAutoimmune disorderProteomicsGene regulation
Poster
Wed Oct 21
2:30 pm
★ Reviewers’ Choice
Genome-wide aggregated trans-effects analysis reveals B-cell activation and checkpoint signalling as therapeutic axes in primary biliary cholangitis
Complex Traits and Polygenic Disorders
Collaborators: Toronto General Hospital, Lunenfeld-Tanenbaum Research Institute
Autoimmune disorderGene regulationGenome-wide association studyIdentification of disease genes
Poster
Wed Oct 21
2:30 pm
From core-gene discovery to mechanism: biological function, accumulating evidence of causality, and rare-variant convergence in essential hypertension
Complex Traits and Polygenic Disorders
Collaborators: Institute of Genetics and Cancer
Cardiovascular systemIdentification of disease genesProteomicsExpression quantitative trait loci
Biomedical Informatics Groupbiomedicalinformaticsgroup.github.io/people
Dry lab~15 people
Develops statistical and machine-learning methods for whole-genome, RNA-seq and clinical data. Targets rare genetic disease diagnosis, autism and Parkinson’s stratification, and cancer biomarker discovery.
7 papers since 2024
Drug-Induced Liver Injury Associated with Turmeric and Piperine: A Case and Review
Case Reports in Gastroenterology, 2025
Embracing Scientific Debate in Brain Metabolism
Journal of Neurochemistry, 2025
Triterpenoid wax esters confirm Ficus religiosa in archaeological sequences within the Mayadevi temple shrine, Lumbini – the birthplace of Buddha
Frontiers in Geochemistry, 2025
Source: OpenAlex author A5069540793
Funded by Wellcome Trust, Simons Foundation for Autism Research Initiative (SFARI) +1 more
UKRI, AI Centre for Doctoral Training in Biomedical Innovation · 2024-2032
“Director UKRI AI Centre for Doctoral Training in Biomedical Innovation (2024-2032)”
Simons Foundation for Autism Research Initiative (SFARI), translational project · Since 2018
“Since 2018 I have been involved in a translational project funded by the Simons Foundation for Autism Research Initiative (SFARI)”
Wellcome Trust · active
“We are using our biomedical natural language processing and network methods in a £5.5m Wellcome Trust funded collaboration”
Source: lab pages
14 platforms and techniques
Analyzes
whole-genome sequencing, RNA microarrays, RNA-seq, single-cell RNA-seq, next-generation sequencing (NGS), high-throughput DNA sequencing
Techniques
network fusion, graph neural networks, biomedical natural language processing, topic modelling, BioBERT, knowledge graphs, Kappa Language rule-based modeling, ordinary differential equation modeling
Source: lab pages
No openings posted
Poster
Fri Oct 23
2:30 pm
A knowledge graph framework for multimodal genotype-phenotype integration in rare genetic diseases
Artificial Intelligence and Machine Learning
Genotype-phenotype correlationsRare variantsMachine learningCharacterization of disorders
Usher Instituteed.ac.uk/usher
Dry lab~284 people
Analyzes Generation Scotland genetic and e-HR data and EAVE II linked GP, vaccination and hospital data. Works with Public Health Scotland on population health.
Funded by Medical Research Council, National Institute for Health Research +4 more
Health Data Research UK, Inflammation and Immunity Driver Programme · 2023-28
“Inflammation and Immunity core funding was awarded by Health Data Research UK (HDR UK).”
Medical Research Council, EAVE II · active
“EAVE II is funded by the Medical Research Council [MR/R008345/1]”
National Institute for Health Research, EAVE II · active
“EAVE II is funded by the Medical Research Council, National Institute for Health Research, Health Data Research UK and the HDR UK BREATHE Hub”
+3 more on the lab page
Source: lab pages
15 platforms and techniques
Analyzes
Generation Scotland, EAVE II, DataLoch Secure Data Environment, Viral sequencing, OMOP Common Data Model, DNA and exome sequencing, MRI and CT scans
Techniques
Genotyping, Machine learning and deep learning, Natural language processing, Statistical modeling, Mendelian randomization, Data linkage, Phylogenetics, Polygenic risk scores
Source: lab pages
Currently hiring
“Join our growing team of academics and professional services staff”
Source: lab positions page
Poster
Thu Oct 22
4:15 pm
Founder effects in the Scottish Isles bring multiple recessive pathogenic variants above the frequency threshold for screening
Evolutionary and Population Genetics
Population geneticsReproductive geneticsRare variantsMendelian disorder

Explore the full ASHG 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.

Privacy

Meeting University of Edinburgh in Montréal?

Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.

Privacy

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction